ETENDERS

Contract notice

Information

Published

Date of dispatch of this notice: 20/04/2018

Expire date: 30/05/2018

External Reference: 2018-086343

TED Reference: 2018/S 079-176043

Contract notice

[NoticeContract]

[Directive201424]

[Section1]: [Ca]

I.1)

[NameAddressContact]

Our Lady's Children's Hospital, Crumlin
N/A
Dublin 12
Dublin
Ireland
IE
[Contactpoint]: robert keogh
[AddressPhone]: +353 014096598
[AddressEmail]: robert.keogh@olhsc.ie
[Nutscode]:  IE -  IRELAND
[Internets]:
[UrlGeneral]: http://www.olchc.ie
[UrlBuyerprofile]: https://irl.eu-supply.com/ctm/Company/CompanyInformation/Index/384

I.3)

[InfoTendering]

[AddressObtainDocs]:  
http://irl.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=126683&B=ETENDERS_SIMPLE
[AddressFurtherinfo]
[AsContactsAbove]:  
[AddressSendTendersRequest]
[AddressToAbove]
I.4)

[CaType]

[MaintypePublicbody]
I.5)

[Mainactivity]

[MainactivHealth]

[Section2]: [Object]

II.1)

[QuantityScopeContract]

II.1.1)

[TitleContract]

Supply of Infliximab or biosimilar
II.1.2)

[CpvMain]

33600000  - 
II.1.3)

[TypeContract]

[Supplies]
II.1.4)

[DescrShort]

To appoint a single provider for the provision, supply, support and delivery of Infliximab or Infliximab biosimilar to patients in Our Lady’s Children’s Hospital Crumlin (OLCHC). It is envisaged that Infliximab-naïve patients in OLCHC will receive the tendered product initially with a view to switch all existing patients within 6 months.
II.1.5)

[ValueMagnitudeEstimatedTotal]

[ValueExclVat]: 1.00  EUR
II.1.6)

[LotsInfo]

[DivisionLots]: [No]
II.2)

[Description]

II.2.2)

[CpvAdditional]

33600000  - 
II.2.3)

[PlacePerformance]

[Nutscode]:  IE -  IRELAND
[MainsiteplaceWorksDelivery]:  
Our Lady's Children's Hospital, Crumlin
II.2.4)

[DescrProcurement]

To appoint a single provider for the provision, supply, support and delivery of Infliximab or Infliximab biosimilar to patients in Our Lady’s Children’s Hospital Crumlin (OLCHC). It is envisaged that Infliximab-naïve patients in OLCHC will receive the tendered product initially with a view to switch all existing patients within 6 months.
II.2.5)

[AwardCriteria]

[AwardCriteriaDescriptive]
II.2.6)

[ValueMagnitudeEstimated]

[ValueExclVat]: 1.00  EUR
II.2.7)

[DurationContractFrameworkDps]

[DurationMonths]: 36
[RenewalsSubject]: [Yes]
[RenewalsDescr]:  
The contract will be for an initial 12 month period with an option to extend to 36 months subject to satisfactory performance. The Hospital reserves the right to seek a review in the event of an increase in usage.
II.2.10)

[VariantsInfo]

[VariantsAccepted]: [Yes]
II.2.11)

[OptionsInfo]

[Options]: [No]
II.2.13)

[EuProgrInfo]

[EuProgrRelated]: [No]

[Section3]: [InfoLegal]

III.1)

[ConditionsParticip]

III.1.1)

[SituationPersonalIncl]

[InfoEvaluatingRequir]:  Must be licensed for use in the Republic of Ireland (ROI) by the Health Products Regulatory Authority (HPRA).
Published data on the use of infliximab or biosimilar infliximab in the paediatric population must be supplied if applicable.
III.1.2)

[EconomicFinancialStanding]

[CriteriaSelectionDocs]
III.1.3)

[TechnicalCapacity]

[CriteriaSelectionDocs]
III.2)

[ConditionsContract]

[Section4]: [Procedure]

IV.1)

[Description]

IV.1.1)

[TypeProcedure]

[ProctypeOpen]
IV.1.8)

[GpaInfo]

[GpaCovered] : [No]
IV.2)

[InfoAdmin]

IV.2.2)

[LimitReceiptTendersReqPart]

[Date]:  27/04/2018
[Time]:  12:00
IV.2.4)

[LanguagesAllowed]

[Language_EN]
IV.2.6)

[MinTimeMaintain]

[DurationMonths] : 36  ([FromStatedDate])
IV.2.7)

[OpeningConditions]

[Date]:  27/04/2018
[Time]:  12:00
[OpeningPlace]:  
Our Lady's Children's Hospital, Crunlin

[Section6]: [InfoComplement]

VI.1)

[RecurrenceInfo]

[RecurrentProcurement]:  [No]
VI.2)

[InfoEworkflow]

[EorderingUsed]
[EinvoicingUsed]
[EpaymentUsed]
VI.4)

[AppealsProcedure]

VI.4.1)

[AppealsBody]

High Court
Inns Quay
Dublin
7
IE